Wake Forest University

This year’s American Society of Hematology (ASH) meeting delivered positive Phase II results for a new daily oral therapy and promising interim Phase I/II data for a one-time base editing treatment fo

What looked like increasing momentum for Larimar Therapeutics, Inc. ’s program to develop the first drug therapy for Friedrich’s ataxia was dashed at least temporarily on 25 May, as the company annou

Abbisko Therapeutics Abbisko brings in $28mm via Series A China-based Abbisko Therapeutics raised $28mm through its Series A financing to Lilly Asia Ventures, Sinopharm Capital, Jianxin Capita

Below is Scrip’s monthly roundup, compiled by Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Boehringer And Vander